Aug 14, 2023NuvOx Announces BARDA Partnership for a Phase Ib ARDS/COVID Trial in CanadaTucson, AZ, August 4th, 2023 - NuvOx Pharma (NuvOx), a clinical stage biotechnology company developing a first-in-class therapeutic to...
Jun 7, 2023NuvOx Announces Glioblastoma Patient Treatment for Phase IIb RESTORE TrialTucson, AZ, May 30, 2023 - NuvOx Pharma (NuvOx), a clinical stage biotechnology company developing a first-in-class therapeutic to treat...
Apr 19, 2023NuvOx Receives SPAN Grant NuvOx Receives SPAN Grant to Conduct Late-stage Preclinical Studies of Putative Neuroprotectants Combined with Reperfusion Tucson, AZ, ...
Mar 5, 2023NuvOx Newly Issued US PatentThe issued patent has claims for methods of use of DDFPe for stroke treatment.